# YUTREPIA
> **NDA213005** · New Drug Application · Sponsor: LIQUIDIA TECH · Approved 2025-05-23
## Drug
- **FDA Application Number:** NDA213005
- **Application type:** New Drug Application
- **Brand name:** YUTREPIA
- **Generic name:** TREPROSTINIL
- **Active ingredients:** TREPROSTINIL SODIUM
- **Dosage form:** POWDER
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** LIQUIDIA TECH
- **Manufacturer:** Liquidia Technologies, Inc.
- **First approval:** 2025-05-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213005)
---
*MORVS · CC0 1.0*